Moshe Talpaz
University of Southern California(US)City Of Hope National Medical Center(US)University of New Mexico(US)University of Michigan–Ann Arbor(US)University of Michigan(US)University of Illinois Chicago(US)City of Hope(US)Michigan Medicine(US)Michigan Center for Translational Pathology(US)Michigan Cancer Research Consortium(US)University of Colorado Cancer Center(US)U-M Rogel Cancer Center(US)University of Colorado Denver(US)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Acute Myeloid Leukemia Research
Most-Cited Works
- → Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia(2001)5,214 cited
- → Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome(2001)2,717 cited
- → Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia(2002)2,026 cited
- → A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis(2012)2,014 cited
- → Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias(2006)1,763 cited
- → The Biology of Chronic Myeloid Leukemia(1999)1,307 cited